Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phenethyl isothiocyanate (PEITC) is a naturally occurring compound found in cruciferous vegetables such as watercress and broccoli. It has been investigated for its chemopreventive and potential antitumor activities, particularly in the context of various cancers including leukemia, lung cancer, and hepatocellular carcinoma. PEITC exerts its effects by targeting multiple proteins involved in cancer cell proliferation, progression, metastasis, and survival. Mechanistically, it induces apoptosis through increased production of reactive oxygen species (ROS), causes cell cycle arrest followed by mitotic catastrophe, downregulates transcription factors like Sp1 (notably affecting androgen receptor expression in prostate cancer), and activates oxeiptosis—a caspase-independent form of programmed cell death. Its antioxidant and anti-inflammatory properties further contribute to its anticancer profile[1][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on phenethyl isothiocyanate.